G. Thomas Budd, M.D.
| Appointed: |
1982 |
| Gender: |
Male |
| Languages: |
English |
Solid Tumor Oncology
Biographical Sketch
George Thomas Budd, MD, is a staff physician in the Taussig Cancer Center at Cleveland Clinic. His clinical interests include breast cancer, sarcomas and experimental therapeutics. His research interests are focused on experimental therapies, breast cancer and sarcomas.
Board-certified in internal medicine with a subspecialty in medical oncology, Dr. Budd has authored more than 100 articles, book chapters and textbooks. He is a reviewer for numerous peer-reviewed publications including Journal of Clinical Oncology, Cancer and Clinical Cancer Research.
In addition, Dr. Budd is a fellow of the American College of Physicians and a member of the Society of Clinical Oncology and American Association for Cancer Research.
Dr. Budd received his medical degree from the University of Kansas Medical School. He completed his internship, residency, and fellowship in medical oncology at Cleveland Clinic.
Education & Fellowships
| Medical School: | University of Kansas School of Medicine, Kansas City, KS |
|
| Residency: | Cleveland Clinic, Internal Medicine, Cleveland, OH |
| Fellowship: | Cleveland Clinic, Medical Oncology, Cleveland, OH |
Certifications
Medical Oncology
Internal Medicine
Specialty Interests
Solid tumors, breast cancer, sarcomas, biologic response modifiers, experimental therapeutics, cancer chemoprevention.
Awards & Honors
Lula Zapis Endowed Chair to support Breast Cancer Research
Professional Memberships
- American Society of Clinical Oncology
- American Association for Cancer Research
- Southwest Oncology Group
- American Medical Association
- American College of Physicians
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/5/2008, Dr. Budd has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Budd receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Wyeth Pharmaceuticals Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
